Protein kinase R is increased and is functional in hepatitis C virus–related hepatocellular carcinoma
暂无分享,去创建一个
Raymond T Chung | Emmett V Schmidt | E. Schmidt | Y. Hiasa | Y. Kamegaya | R. Chung | M. Kohara | M. Onji | Michinori Kohara | Yoichi Hiasa | Morikazu Onji | Yoshitaka Kamegaya | Hideko Nuriya | H. Nuriya
[1] J. Hershey,et al. 2 The Pathway and Mechanism of Eukaryotic Protein Synthesis , 1996 .
[2] M. Mathews,et al. Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR , 2000, Oncogene.
[3] P. Delvenne,et al. Detection of human papillomavirus DNA in formalin-fixed tissues by in situ hybridization after amplification by polymerase chain reaction. , 1991, The American journal of pathology.
[4] A. Haase,et al. Amplification and detection of lentiviral DNA inside cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Katze,et al. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] N. Sonenberg,et al. Abrogation of translation initiation factor eIF‐2 phosphorylation causes malignant transformation of NIH 3T3 cells. , 1995, The EMBO journal.
[7] C. Proud,et al. PKR: a new name and new roles. , 1995, Trends in biochemical sciences.
[8] M J Clemens,et al. The double-stranded RNA-dependent protein kinase PKR: structure and function. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[9] B. Williams,et al. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin , 2000, The EMBO journal.
[10] M. Satoh,et al. Tumor Necrosis Factor-α–Converting Enzyme and Tumor Necrosis Factor-α in Human Dilated Cardiomyopathy , 1999 .
[11] M. Alter,et al. Epidemiology of Hepatitis C , 2018, Clinical liver disease.
[12] D. R. Taylor,et al. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.
[13] N. Terrault,et al. Hepatitis C and hepatocellular carcinoma , 2001, Current treatment options in oncology.
[14] M. Katze,et al. The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Katze,et al. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[16] Michael G. Katze,et al. Regulation of mRNA Translation and Cellular Signaling by Hepatitis C Virus Nonstructural Protein NS5A , 2001, Journal of Virology.
[17] M. Katze,et al. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. , 1992, Science.
[18] R. Silverman,et al. RNA-Dependent Protein Kinase PKR Is Required for Activation of NF-κB by IFN-γ in a STAT1-Independent Pathway1 , 2001, The Journal of Immunology.
[19] H. W. Chang,et al. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] T. Hibi,et al. Augmented levels of gastric mucosal leucocyte activation by infection with cagA gene‐positive Helicobacter pylori , 1998, Journal of gastroenterology and hepatology.
[21] A. Hinnebusch,et al. Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR , 1996, Molecular and cellular biology.
[22] M. Katze,et al. Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and vaccinia virus K3L is mediated by unique domains: implications for kinase regulation , 1996, Molecular and cellular biology.
[23] J. Neuberger,et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. , 1997, Journal of hepatology.
[24] I. Kerr,et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.
[25] G. Duverlie,et al. Expression of Hepatitis C Virus Proteins Interferes with the Antiviral Action of Interferon Independently of PKR-Mediated Control of Protein Synthesis , 2000, Journal of Virology.
[26] M. Katze,et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. , 1997, Virology.
[27] O. Elroy-Stein,et al. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. , 1993, The Journal of biological chemistry.
[28] M. Katze,et al. Antiapoptotic and Oncogenic Potentials of Hepatitis C Virus Are Linked to Interferon Resistance by Viral Repression of the PKR Protein Kinase , 1999, Journal of Virology.
[29] B. Williams,et al. The role of the dsRNA-activated kinase, PKR, in signal transduction , 1995 .
[30] H. Kawasaki,et al. Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. , 1998, Cancer research.
[31] M. Mathews,et al. A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2 , 1976, Cell.
[32] M. Koffler. Epidemiology of hepatitis. , 1965, Lancet.
[33] Michael G. Katze,et al. Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation , 1998, Molecular and Cellular Biology.
[34] M. Katze,et al. Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. , 1992, The Journal of biological chemistry.
[35] M. Katze,et al. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation , 1995, Molecular and cellular biology.
[36] L. Beretta,et al. Activation of the interferon-inducible protein kinase PKR by Hepatocellular carcinoma derived-Hepatitis C virus core protein , 2001, Oncogene.
[37] N. Méndez-Sánchez. [Epidemiology of hepatitis C]. , 2002, Revista de gastroenterologia de Mexico.
[38] H. W. Chang,et al. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. , 1991, Virology.
[39] Michael B. Mathews,et al. A mechanism for the control of protein synthesis by adenovirus VA RNAI , 1986, Cell.